AxoGen (AXGN) News Today $17.04 -0.65 (-3.67%) Closing price 04:00 PM EasternExtended Trading$16.24 -0.80 (-4.72%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period FY2025 EPS Estimates for AxoGen Raised by Leerink PartnrsAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Investment analysts at Leerink Partnrs boosted their FY2025 earnings per share (EPS) estimates for AxoGen in a note issued to investors on Monday, March 31st. Leerink Partnrs analyst M. Kratky now expects that the medical equipment provider will post earApril 3 at 6:18 AM | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Sees Significant Drop in Short InterestAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) was the target of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 1,510,000 shares, a decrease of 18.4% from the February 28th total of 1,850,000 shares. Based on an average daily trading volume, of 539,900 shares, the short-interest ratio is currently 2.8 days. Approximately 3.7% of the company's shares are sold short.April 2 at 6:19 AM | marketbeat.comPrudential Financial Inc. Has $6.89 Million Stake in AxoGen, Inc. (NASDAQ:AXGN)Prudential Financial Inc. reduced its position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 3.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 418,285 shares of the medical equipment provider's stock afApril 1 at 3:47 AM | marketbeat.comAxoGen (NASDAQ:AXGN) Stock Price Up 4.8% - What's Next?AxoGen (NASDAQ:AXGN) Trading Up 4.8% - What's Next?March 26, 2025 | marketbeat.comRaymond James Financial Inc. Makes New Investment in AxoGen, Inc. (NASDAQ:AXGN)Raymond James Financial Inc. purchased a new stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 276,200 shares of the medical equipment prMarch 26, 2025 | marketbeat.comAxogen: LT Bullish, But Outcomes Weighted To Downside, At This PointMarch 25, 2025 | seekingalpha.comPerkins Capital Management Inc. Sells 22,175 Shares of AxoGen, Inc. (NASDAQ:AXGN)Perkins Capital Management Inc. decreased its holdings in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 7.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 261,224 shares of the medical equipment pMarch 25, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $6.87 Million Position in AxoGen, Inc. (NASDAQ:AXGN)Charles Schwab Investment Management Inc. raised its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 14.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 416,610 shares of the medical equipment provider's stock after purchasing an additionMarch 25, 2025 | marketbeat.comAxoGen appoints Rick Ditto as VP, global health economics, reimbursment & policyMarch 25, 2025 | markets.businessinsider.comInsider Selling: AxoGen, Inc. (NASDAQ:AXGN) Insider Sells 15,111 Shares of StockAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) insider Erick Wayne Devinney sold 15,111 shares of the firm's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $17.50, for a total value of $264,442.50. Following the completion of the transaction, the insider now owns 217,762 shares of the company's stock, valued at approximately $3,810,835. This represents a 6.49 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.March 20, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Shares Down 2.9% - Should You Sell?AxoGen (NASDAQ:AXGN) Shares Down 2.9% - Time to Sell?March 20, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Insider Sells $264,442.50 in StockMarch 20, 2025 | insidertrades.comAxoGen, Inc. (NASDAQ:AXGN) Given Consensus Rating of "Buy" by BrokeragesShares of AxoGen, Inc. (NASDAQ:AXGN - Get Free Report) have received an average recommendation of "Buy" from the four analysts that are currently covering the firm, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation. The average 1 year priceMarch 18, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Coverage Initiated at Lake Street CapitalLake Street Capital initiated coverage on shares of AxoGen in a research note on Monday. They issued a "buy" rating and a $30.00 price target on the stock.March 18, 2025 | marketbeat.comLake Street Initiates Coverage of Axogen (AXGN) with Buy RecommendationMarch 18, 2025 | msn.comTocqueville Asset Management L.P. Has $9.72 Million Stock Position in AxoGen, Inc. (NASDAQ:AXGN)Tocqueville Asset Management L.P. decreased its position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 15.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 589,900 shares of the medical equipmeMarch 18, 2025 | marketbeat.comCounterpoint Mutual Funds LLC Invests $565,000 in AxoGen, Inc. (NASDAQ:AXGN)Counterpoint Mutual Funds LLC purchased a new position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 34,275 shares of the medical equipment provider's stock, valued at approximately $565,000. CMarch 18, 2025 | marketbeat.comAxogen, Inc. (NASDAQ:AXGN) is a favorite amongst institutional investors who own 75%March 18, 2025 | finance.yahoo.comAxoGen initiated with a Buy at Lake StreetMarch 17, 2025 | markets.businessinsider.comConnor Clark & Lunn Investment Management Ltd. Decreases Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN)Connor Clark & Lunn Investment Management Ltd. decreased its position in AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 6.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 288,745 shares of the medical equipment provider'sMarch 17, 2025 | marketbeat.comAxoGen’s SWOT analysis: nerve repair innovator’s stock poised for growthMarch 13, 2025 | uk.investing.comCantor Fitzgerald maintains AxoGen stock overweight ratingMarch 7, 2025 | uk.investing.comInsider Selling: AxoGen, Inc. (NASDAQ:AXGN) Director Sells 5,000 Shares of StockAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) Director Amy Mcbride Wendell sold 5,000 shares of AxoGen stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $20.02, for a total value of $100,100.00. Following the completion of the transaction, the director now owns 97,899 shares of the company's stock, valued at $1,959,937.98. This trade represents a 4.86 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.March 6, 2025 | marketbeat.comCantor Fitzgerald Reaffirms Overweight Rating for AxoGen (NASDAQ:AXGN)Cantor Fitzgerald reiterated an "overweight" rating and issued a $24.00 price objective on shares of AxoGen in a report on Wednesday.March 6, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Director Amy Mcbride Wendell Sells 5,000 SharesMarch 6, 2025 | insidertrades.comAxoGen (NASDAQ:AXGN) Shares Down 6.1% - Time to Sell?AxoGen (NASDAQ:AXGN) Stock Price Down 6.1% - Here's What HappenedMarch 5, 2025 | marketbeat.com14,285 Shares in AxoGen, Inc. (NASDAQ:AXGN) Bought by Y Intercept Hong Kong LtdY Intercept Hong Kong Ltd bought a new stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 14,285 shares of the medical equipment provider's stock, valued at approximately $235,000. Several other institutionaMarch 5, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Purchased by New York State Common Retirement FundNew York State Common Retirement Fund boosted its stake in shares of AxoGen, Inc. (NASDAQ:AXGN - Free Report) by 63.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 69,629 shares of the medical equipment provider's stock aMarch 4, 2025 | marketbeat.comLeerink Partnrs Forecasts AxoGen FY2029 EarningsAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Equities researchers at Leerink Partnrs issued their FY2029 earnings per share (EPS) estimates for shares of AxoGen in a report issued on Tuesday, February 25th. Leerink Partnrs analyst M. Kratky expects that the medical equipment provider will earn $0.3March 1, 2025 | marketbeat.comFY2025 EPS Estimates for AxoGen Lowered by Cantor FitzgeraldAxoGen, Inc. (NASDAQ:AXGN - Free Report) - Equities research analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for shares of AxoGen in a report issued on Wednesday, February 26th. Cantor Fitzgerald analyst R. Osborn now forecasts that the medical equipment provider wMarch 1, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Price Target Raised to $26.00 at Canaccord Genuity GroupCanaccord Genuity Group increased their price objective on shares of AxoGen from $22.00 to $26.00 and gave the company a "buy" rating in a report on Wednesday.February 27, 2025 | marketbeat.comAxoGen price target raised to $26 from $22 at CanaccordFebruary 26, 2025 | markets.businessinsider.comAxoGen price target raised to $26 from $20 at Citizens JMPFebruary 26, 2025 | markets.businessinsider.comAxogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ...February 26, 2025 | finance.yahoo.comAxogen shares surge 11% on Q4 earnings beat, strong revenue growthFebruary 25, 2025 | za.investing.comAxogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial ResultsFebruary 25, 2025 | markets.businessinsider.comAxoGen price target raised to $25 from $18 at LeerinkFebruary 25, 2025 | markets.businessinsider.comAxogen, Inc. (AXGN) Q4 2024 Earnings Call TranscriptFebruary 25, 2025 | seekingalpha.comAxoGen (NASDAQ:AXGN) Shares Gap Down on Disappointing EarningsAxoGen (NASDAQ:AXGN) Shares Gap Down Following Weak EarningsFebruary 25, 2025 | marketbeat.comAxoGen (NASDAQ:AXGN) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPSAxoGen (NASDAQ:AXGN - Get Free Report) announced its quarterly earnings data on Tuesday. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.03). AxoGen had a negative return on equity of 14.91% and a negative net margin of 7.91%.February 25, 2025 | marketbeat.comAxogen, Inc. To Host Analyst & Investor Day on March 4thFebruary 25, 2025 | globenewswire.comAxoGen (NASDAQ:AXGN) Sets New 1-Year High - What's Next?AxoGen (NASDAQ:AXGN) Sets New 1-Year High - Here's WhyFebruary 22, 2025 | marketbeat.comHussman Strategic Advisors Inc. Takes $519,000 Position in AxoGen, Inc. (NASDAQ:AXGN)Hussman Strategic Advisors Inc. acquired a new stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,500 shares of the medical equipment provider'sFebruary 22, 2025 | marketbeat.comAxoGen (AXGN) Expected to Announce Earnings on TuesdayAxoGen (NASDAQ:AXGN) will be releasing earnings before the market opens on Tuesday, February 25. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=236575)February 21, 2025 | marketbeat.comWe Might See A Profit From Axogen, Inc. (NASDAQ:AXGN) SoonFebruary 18, 2025 | uk.finance.yahoo.comAxoGen, Inc. (NASDAQ:AXGN) Short Interest Up 50.8% in JanuaryAxoGen, Inc. (NASDAQ:AXGN - Get Free Report) was the target of a significant growth in short interest in January. As of January 31st, there was short interest totalling 1,870,000 shares, a growth of 50.8% from the January 15th total of 1,240,000 shares. Based on an average daily trading volume, of 416,600 shares, the days-to-cover ratio is currently 4.5 days.February 13, 2025 | marketbeat.comAxogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025February 11, 2025 | globenewswire.comAxoGen (NASDAQ:AXGN) Sets New 1-Year High - Here's What HappenedAxoGen (NASDAQ:AXGN) Reaches New 1-Year High - Here's WhyFebruary 6, 2025 | marketbeat.comCalamos Advisors LLC Acquires New Position in AxoGen, Inc. (NASDAQ:AXGN)Calamos Advisors LLC bought a new stake in AxoGen, Inc. (NASDAQ:AXGN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 31,725 shares of the medical equipment provider's stock, valued at approximately $523,000February 6, 2025 | marketbeat.comAxoGen price target raised to $22 from $18 at CanaccordFebruary 3, 2025 | markets.businessinsider.com Remove Ads Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address AXGN Media Mentions By Week AXGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXGN News Sentiment▼1.240.60▲Average Medical News Sentiment AXGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXGN Articles This Week▼63▲AXGN Articles Average Week Remove Ads Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SLNO News PRCT News NVST News TMDX News ENOV News LIVN News NVCR News LMAT News WRBY News CNMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXGN) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AXGN Stock Free AXGN Stock Alerts